创新链/学科链/研发链/产业链

新药研发前沿动态 / 医药领域趋势进展

Advanced Search

column
Research Progress in and Countermeasures against Carcinogenicity of Aristolochic Acids and Their Derivatives
BAI Zhaofang, XU Guang, WANG Jiabo, XIAO Xiaohe
2018, 42(3): 164-169.
Abstract PDF
Research Advances in Prevention and Treatment of Glucocorticoid-induced Osteoporosis
GE Yonghan, SHU Qing, GE Weihong
2018, 42(3): 170-176.
Abstract PDF
Research Progress in Inhibitors against Bacterial β-Glucuronidase in Gastrointestinal Tract
WENG Zimiao, LYU Shanshan, GE Guangbo, WANG Ping, HOU Jie
2018, 42(3): 177-186.
Abstract PDF
Model Based Meta-analysis in Drug Development
WEI Chunxiang, HE Hua, LIU Xiaoquan
2018, 42(3): 187-192.
Abstract PDF
Recent Advances in Mass Spectrometry-based Identification of Drug Metabolites
WANG Huiying, WANG Rui, YANG Hua, LI Ping
2018, 42(3): 193-200.
Abstract PDF
Immunometabolic Signaling Pathways Based Researches on Non-alcoholic Steatohepatitis and Intervention by Traditional Chinese Medicines
FAN Qilin, ZHENG Xia, ZHANG Yubin
2018, 42(3): 201-206.
Abstract PDF
Advances in Isocitrate Dehydrogenase and the Inhibitors of Its Mutants for Acute Myeloid Leukemia
HUANG He, LIU Xiaorong, YOU Qidong
2018, 42(3): 207-213.
Abstract PDF
Advances in Research on Bromodomain Inhibitors and Their Applications in Human Diseases
BIAN Yuanyuan, MA Yu, CHEN Yadong, TANG Weifang
2018, 42(3): 214-221.
Abstract PDF
Research Advances in Metabolism of Phenolic Compounds by UGTs and the Mediated Drug-drug Interactions
HU Guangnan, ZHANG Zunjian, SONG Rui
2018, 42(3): 222-230.
Abstract PDF
Research Advances in Development of Regeneration Family Proteins as Novel Drugs
LI Xiang, ZHANG Xueqing, YIN Tianqi, WANG Min
2018, 42(3): 231-237.
Abstract PDF
An Overview of New Drugs Approved in the US, EU and Japan in February 2018
SUN Yousong
2018, 42(3): 238-240.
Abstract PDF